“Grand View Research, Inc. – Market Research And Consulting.”

The global cancer registry software market size is expected to reach USD 103.5 million by 2026, exhibiting a CAGR of 10.5%. The growing incidence of cancer is expected to aid growth over the forecast period. Currently, cancer is the second leading cause of death globally, and according to WHO, around 70% of the deaths occur in low- and middle-income countries.

Moreover, the rising adoption of Electronic Health Records (EHRs) in developed countries and the increasing need for cancer registries for post-marketing surveillance are among the factors further anticipated to boost the demand for cancer registry software in the coming years. Market players are constantly involved in software updation in an attempt to minimize security risks and provide efficient software, thereby increasing market visibility and adoption. For instance, in April 2018, Elekta invested in PalabraApps LLC to improve its MOSAIQ Oncology Information System software.

An increasing number of clinical trials being conducted by major pharmaceutical and biotechnological companies is expected to drive the market over the forecast period. Cancer registry data helps in tracking patients for clinical trials. Moreover, the affected locations for any specific type of cancer can be identified by using this software. Major pharmaceutical companies are increasingly preferring cancer registry software owing to less requirement of internal staff, increased cost-effectiveness, and efficient management of resources, which is further widening the scope for growth.

Cancer Registry Software Market Report Highlights

1. On the basis of software, the standalone segment dominated the global market in 2018. This became possible owing to the advanced features and automatic upgrade features of standalone software which tends to help reduce IT overhead costs.

2. The integrated software segment is expected to demonstrate substantial growth during the forecast period due to the growing need for software integration with the regional oncology network. This helps in monitoring the affected geographical locations and to assess clinical intervention.

3. Based on the deployment model, the on-premise segment dominated the market due to high data security and low risk of a data breach.

4. The cloud-based segment is projected to witness significant growth over the forecast period owing to the reduced installation charges and IT overhead costs.

5. Based on components, the commercial segment held the largest revenue share as of 2018 owing to its advantage of data safety as compared to the public database.

6. North America held the largest revenue share as of 2018 due to supportive government initiatives and the presence of key industry players.

7. The Asia Pacific is anticipated to witness lucrative growth due to increasing government initiatives and the presence of untapped opportunities.

8. In March 2020, Inspirata launched new cancer and clinical data extraction software service. The software standardizes patient data from clinical records by leveraging the power of artificial intelligence (AI) and natural language processing (NLP), then recognizes essential cancer information, defines the related context, and provides expert analysis.

“Would you Like/Try a Sample Report” Click the link below: https://www.grandviewresearch.com/industry-analysis/cancer-registry-software-market/request/rs1

Cancer Registry Software Market Segmentation

Grand View Research has segmented the global cancer registry software market on the basis of software, deployment model, component, end use, and region:

Cancer Registry Software, Software Outlook (Revenue, USD Million, 2014 – 2026)

• Standalone

• Integrated

Cancer Registry Software Deployment Model Outlook (Revenue, USD Million, 2014 – 2026)

• On-premise

• Cloud-based

Cancer Registry Software Component Outlook (Revenue, USD Million, 2014 – 2026)

• Commercial

• Public

Cancer Registry Software End-use Outlook (Revenue, USD Million, 2014 – 2026)

• Government & third party

• Private payers

• Hospital & medical practice

• Pharma biotech & medical device companies

• Research institutes

Cancer Registry Software Regional Outlook (Revenue, USD Million, 2014 – 2026)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Russia

• Asia Pacific

  • Japan

  • China

  • India

• Latin America

  • Brazil

  • Mexico

• Middle East & Africa

• South Africa

• Saudi Arabia

List of Key Players of Cancer Registry Software Market

• Elekta
• C/NET Solutions
• Electronic Registry Systems Inc.
• Onco Inc.
• McKesson Corporation
• Rocky Mountain

Have Any Query? Ask Our Experts for More Details on Report: https://www.grandviewresearch.com/inquiry/6632/ibb

Browse Related Report @

Patient Registry Software Market – https://www.grandviewresearch.com/industry-analysis/patient-registry-software-market

Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research is a market research and consulting company that offers market research reports, syndicated and customized reports. The company is headquartered in San Francisco, California. It offers client engagement for business consulting and market intelligence from various domains. The clientele is based across various countries with queries coming from more than 50 industries worldwide.
Grand View Research helps its clients to make informed decisions by helping them understand current trends and scenarios. Every year Grand View Research accomplishes more than 300 multi-country market studies to optimize consulting for clients.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/cancer-registry-software-market